Skip to content

Category

small language model

3,317 papers

#computer vision Open access Jul 2025

A scalable and quantum-accurate foundation model for biomolecular force fields via linearly tensorized quadrangle attention

LiTEN achieves state-of-the-art accuracy on standard benchmarks, consistently outperforming leading approaches in both precision and speed, and enables comprehensive modeling tasks, ranging from geometry optimization to free energy surface construction, with high computational efficiency for large biomolecules.

Qun Su, Kai Zhu, Qiaolin Gou et al. · 2 citations
#machine learning Open access Nov 2025

mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset

The authors develop mRNABERT, a foundational AI model that designs entire mRNA sequences and demonstrates superior performance across comprehensive benchmarks, which signifies a substantial leap forward in mRNA research and therapeutic development.

Ying Xiong, Aowen Wang, Yu Kang et al. · 23 citations · ⚡1
#machine learning Open access Sep 2025

Unified and explainable molecular representation learning for imperfectly annotated data from the hypergraph view

OmniMol is presented, a framework using hypergraphs to improve predictions of molecular properties, addressing challenges of imperfect data annotation and enhancing model explainability, and achieves state-of-the-art performance in properties prediction.

Bowen Wang, Junyou Li, Donghao Zhou et al. · 11 citations
#machine learning Open access May 2025

Token-Mol 1.0: tokenized drug design with large language models

Token-Mol is presented, a token-only 3D drug design model that encodes both 2D and 3D structural information, along with molecular properties, into discrete tokens, which introduces a Gaussian cross-entropy loss function tailored for regression tasks, enabling superior performance across multiple downstream application...

Ji-Ke Wang, Rui Qin, Mingyang Wang et al. · 30 citations · ⚡1
#machine learning Open access Nov 2025

A fused deep learning approach to transform drug repositioning

A deep learning framework that integrates knowledge graph embedding and pre-training strategies to overcome the intractable cold start issue, achieving superior performance and interpretability in drug repurposing is introduced.

Kun Li, Jiacai Yi, Qing Ye et al. · 1 citation
#machine learning Open access Jun 2025

HiCLR: Knowledge-Induced Hierarchical Contrastive Learning with Retrosynthesis Prediction Yields a Reaction Foundation Model

HiCLR is the first foundation model that can be broadly applied to various synthesis-related tasks, and it achieves state-of-the-art performance in reaction classification, reaction condition recommendation, reaction yield prediction, synthesis planning, and even molecular property prediction.

Jialu Wu, Yiheng Zhu, Xiaorui Wang et al. · 0 citations
#machine learning Open access Jul 2025

RSGPT: a generative transformer model for retrosynthesis planning pre-trained on ten billion datapoints

RSGPT, a generative model pre-trained on ten billion data points, achieving state-of-the-art performance for synthesis planning, and introduces reinforcement learning to capture the relationships among products, reactants, and templates more accurately.

Yafeng Deng, Xinda Zhao, Hanyu Sun et al. · 18 citations · ⚡2
#machine learning Open access Aug 2026

AI-driven PROTAC design overcomes oncogenic resilience by eliminating the CLIP1-LTK fusion protein.

The AI-guided development of a first-in-class proteolysis-targeting chimera (PROTAC) designed to selectively degrade the CLIP1-LTK fusion protein is reported, providing a promising therapeutic strategy for overcoming acquired resistance in kinase-driven cancers.

Shi-Cheng Chen, Hai-Ting Duan, S. Zhong et al. · 0 citations
#machine learning Open access Apr 2026

Accurate and task-agnostic modeling of enzymatic reactions through multimodal relational learning

ERAM aligns pre-trained molecular representations from Protein Language Model with the knowledge of enzyme catalysis by modeling enzymatic reactions as multi-relational data, and demonstrates its potential as a versatile and effective tool for enzyme catalysis research.

Yuansheng Huang, Lanqing Li, Wenjia Qian et al. · 2 citations
#natural language process... Open access Apr 2026

LaMGen: LLM-based 3D molecular generation for multi-target drug design

This study introduces LaMGen, an LLM-powered framework that leverages large-scale protein-ligand data and rotation-aware molecular encoding to rapidly produce chemically plausible multi-target candidates, achieving strong zero-shot generalization, superior molecular quality, and robust performance across dual- and trip...

Qun Su, Qiaolin Gou, Hui Zhang et al. · 1 citation
#machine learning Open access Jul 2026

BBBP-Atlas: Unified Interpretable Modeling of Blood–Brain Barrier Permeability across Small Molecules and Peptides

BBBP-Atlas is proposed, a structure-aware BBB permeability prediction model designed for unified modeling of small molecules and peptides with the first cross-modal dataset OmniBBBP, which offers a versatile and cross-modal approach for single-compound prediction, batch screening, and dataset exploration for CNS drug d...

Xin Shen, Qun Su, Hao Luo et al. · 0 citations

From tech blogs

See all →
MIT News · Artificial Intelligence Oct 23, 2026

Q&A: How AI came to model the “messy” human mind

Assistant Professor Benjamin Lindquist studies how engineers deliberately injected randomness into early AI, giving rise to deep-learning models that sometimes hallucinate.

Microsoft Research Blog Oct 22, 2026

Flint-interactive: A language for creating interactive data visualizations

Flint-interactive gives AI agents a language for creating interactive visualizations. Click a chart, filter data, highlight related content, and explore beyond the view the author originally chose. The post Flint-interactive: A language for creating interactive data visualizations appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.